XERIS PHARMACEUTICALS INC Operating Income
XERIS PHARMACEUTICALS INC reported Operating Income of -$25.79 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2021-08-05
- XERIS PHARMACEUTICALS INC operating income (loss) for the quarter ending 2021-06-30 was -$25.79M.
- XERIS PHARMACEUTICALS INC operating income (loss) for the quarter ending 2021-03-31 was -$16.74M.
- XERIS PHARMACEUTICALS INC operating income (loss) for the quarter ending 2020-12-31 was -$19.34M.
- XERIS PHARMACEUTICALS INC operating income (loss) for the quarter ending 2020-09-30 was -$13.74M.
- XERIS PHARMACEUTICALS INC operating income (loss) for fiscal 2020 was -$83.55M.
- XERIS PHARMACEUTICALS INC operating income (loss) for fiscal 2019 was -$122.38M.
- XERIS PHARMACEUTICALS INC operating income (loss) for fiscal 2018 was -$59.34M.
- XERIS PHARMACEUTICALS INC operating income (loss) for fiscal 2017 was -$26.63M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$25.79M 10-Q · filed 2021-08-05 | -$42.53M 10-Q · filed 2021-08-05 | -$61.87M derived: sum of 3 quarters · filed 2021-08-05 | -$75.61M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | -$16.74M 10-Q · filed 2021-05-13 | -$36.08M derived: sum of 2 quarters · filed 2021-05-13 | -$49.83M derived: sum of 3 quarters · filed 2021-05-13 | -$72.03M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-12-31 | -$19.34M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$33.09M derived: sum of 2 quarters · filed 2021-03-09 | -$55.29M derived: sum of 3 quarters · filed 2021-08-05 | -$83.55M 10-K · filed 2021-03-09 |
| 2020-09-30 | -$13.74M 10-Q · filed 2020-11-09 | -$35.95M derived: sum of 2 quarters · filed 2021-08-05 | -$64.20M 10-Q · filed 2020-11-09 | -$97.00M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-06-30 | -$22.20M 10-Q · filed 2021-08-05 | -$50.46M 10-Q · filed 2021-08-05 | -$83.26M derived: sum of 3 quarters · filed 2021-08-05 | -$113.34M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$28.25M 10-Q · filed 2021-05-13 | -$61.05M derived: sum of 2 quarters · filed 2021-05-13 | -$91.14M derived: sum of 3 quarters · filed 2021-05-13 | -$125.20M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$32.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$62.88M derived: sum of 2 quarters · filed 2021-03-09 | -$96.94M derived: sum of 3 quarters · filed 2021-03-09 | -$122.38M 10-K · filed 2021-03-09 |
| 2019-09-30 | -$30.08M 10-Q · filed 2020-11-09 | -$64.14M derived: sum of 2 quarters · filed 2020-11-09 | -$89.58M 10-Q · filed 2020-11-09 | -$109.89M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | -$34.06M 10-Q · filed 2020-08-10 | -$59.50M 10-Q · filed 2020-08-10 | -$79.81M derived: sum of 3 quarters · filed 2020-08-10 | -$94.75M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | -$25.44M 10-Q · filed 2020-05-07 | -$45.75M derived: sum of 2 quarters · filed 2020-05-07 | -$60.69M derived: sum of 3 quarters · filed 2020-05-07 | -$73.05M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | -$20.31M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$35.26M derived: sum of 2 quarters · filed 2020-03-12 | -$47.61M derived: sum of 3 quarters · filed 2020-03-12 | -$59.34M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$14.94M 10-Q · filed 2019-11-07 | -$27.30M derived: sum of 2 quarters · filed 2019-11-07 | -$39.03M 10-Q · filed 2019-11-07 | -$48.24M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$12.36M 10-Q · filed 2019-08-06 | -$24.09M 10-Q · filed 2019-08-06 | -$33.30M derived: sum of 3 quarters · filed 2019-08-06 | -$40.87M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | -$11.73M 10-Q · filed 2019-05-09 | -$20.94M derived: sum of 2 quarters · filed 2019-05-09 | -$28.51M derived: sum of 3 quarters · filed 2019-05-09 | -$33.71M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | -$9.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$16.78M derived: sum of 2 quarters · filed 2019-03-06 | -$21.98M derived: sum of 3 quarters · filed 2019-03-06 | -$26.63M 10-K · filed 2019-03-06 |
| 2017-09-30 | -$7.57M 10-Q · filed 2018-11-08 | -$12.77M derived: sum of 2 quarters · filed 2018-11-08 | -$17.42M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | -$5.20M 10-Q · filed 2018-08-14 | -$9.85M 10-Q · filed 2018-08-14 |